UNOMR, an ETH project at the cutting edge of serial interface nanopore technology for proteomics, is thrilled to announce a successful funding round in which we raised $184,000. This achievement marks a significant milestone in our journey to revolutionize proteomics research and accelerate advancements in nanopore technology. The new capital will be strategically deployed to boost our research and development efforts, enabling us to refine our pioneering nanopore platform and extend its capabilities for high-throughput, accurate protein analysis. With this injection of funds, UNOMR will invest in acquiring state-of-the-art equipment and scaling up our experimental processes to streamline data acquisition and analysis. Additionally, we plan to expand our talented research team, fostering collaborations with leading experts in the field, both in academic and industrial settings, to ensure that our technology meets the highest standards of innovation and practical applicability. This funding round not only validates our vision and the groundbreaking nature of our work but also empowers us to push the boundaries of what is currently possible in proteomics research. As we further explore the integration and automation of nanopore technologies, our aim is to bridge the gap between fundamental research and real-world applications, such as precision medicine and biotechnology. We extend our heartfelt thanks to our investors and supporters for believing in our mission. Their confidence in our endeavors inspires us to continue our pursuit of excellence and transform the landscape of proteomics through innovative, reliable, and scalable nanopore solutions.







